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Abstract
Introduction: HIV planning requires granular estimates for the number of people living with HIV (PLHIV), antiretroviral treat-
ment (ART) coverage and unmet need, and new HIV infections by district, or equivalent subnational administrative level. We
developed a Bayesian small-area estimation model, called Naomi, to estimate these quantities stratified by subnational admin-
istrative units, sex, and five-year age groups.
Methods: Small-area regressions for HIV prevalence, ART coverage and HIV incidence were jointly calibrated using subna-
tional household survey data on all three indicators, routine antenatal service delivery data on HIV prevalence and ART cov-
erage among pregnant women, and service delivery data on the number of PLHIV receiving ART. Incidence was modelled by
district-level HIV prevalence and ART coverage. Model outputs of counts and rates for each indicator were aggregated to
multiple geographic and demographic stratifications of interest. The model was estimated in an empirical Bayes framework,
furnishing probabilistic uncertainty ranges for all output indicators. Example results were presented using data from Malawi
during 2016–2018.
Results: Adult HIV prevalence in September 2018 ranged from 3.2% to 17.1% across Malawi’s districts and was higher in
southern districts and in metropolitan areas. ART coverage was more homogenous, ranging from 75% to 82%. The largest
number of PLHIV was among ages 35 to 39 for both women and men, while the most untreated PLHIV were among ages 25
to 29 for women and 30 to 34 for men. Relative uncertainty was larger for the untreated PLHIV than the number on ART
or total PLHIV. Among clients receiving ART at facilities in Lilongwe city, an estimated 71% (95% CI, 61% to 79%) resided
in Lilongwe city, 20% (14% to 27%) in Lilongwe district outside the metropolis, and 9% (6% to 12%) in neighbouring Dowa
district. Thirty-eight percent (26% to 50%) of Lilongwe rural residents and 39% (27% to 50%) of Dowa residents received
treatment at facilities in Lilongwe city.
Conclusions: The Naomi model synthesizes multiple subnational data sources to furnish estimates of key indicators for HIV
programme planning, resource allocation, and target setting. Further model development to meet evolving HIV policy priorities
and programme need should be accompanied by continued strengthening and understanding of routine health system data.
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1 INTRODUCT ION
The global community has established ambitious goals for
expanding coverage of antiretroviral treatment (ART) and
reducing new HIV infections to end AIDS as a public health
threat by 2030 [1]. To reach these goals, HIV planning and
resource allocation are increasingly undertaken at the district
level where health services are typically administered, partic-
ularly in countries in sub-Saharan Africa with the largest HIV
epidemics. Establishing meaningful targets requires accurate
and current estimates for the burden of HIV, new infections,
and existing ART coverage in priority locations, sexes and age
groups.
HIV programmes in sub-Saharan Africa annually produce
national estimates of HIV epidemic trends using the UNAIDS-
supported Spectrum and Estimation and Projection Package
(EPP) models [2]. Spectrum is an integrated demographic and
HIV epidemic projection model that estimates rates of HIV
infection, disease progression, and mortality by sex and age
since the start of the HIV epidemic, accounting for the impact
of ART and prevention of mother-to-child transmission pro-
grammes [3,4]. EPP statistically estimates HIV transmission
rates throughout the epidemic to infer HIV incidence trends
from HIV prevalence data [5].
The main challenge for robust subnational estimates is
sparse data at the district level. HIV prevalence estimates
from household surveys are reasonably precise at the national
level, but the sample size within each district is often very
small. Spatial smoothing and geostatistical models have been
applied effectively to estimate subnational HIV prevalence
and the number of people living with HIV (PLHIV) [6–12].
HIV prevalence among pregnant women from antenatal clinic
(ANC) sentinel surveillance or routine HIV testing of ANC
clients has consistently been found to be an informative pre-
dictor of spatial variation in population-wide HIV prevalence
[9,10,13–16].
Quantifying ART coverage and unmet need in subnational
areas has received less attention. Recent household surveys
have included biomarker tests for antiretroviral use, which
may inform spatial patterns of treatment coverage [17,18].
National treatment coverage is conventionally estimated by
comparing the number currently receiving ART from national
health information systems with independently modelled esti-
mates for the number of PLHIV [19]. This approach may
lead to inaccurate estimates at finer geographic levels due to
imprecision of the PLHIV denominator or ART clients attend-
ing health facilities outside their district of residence [20,21].
To systematically utilize district-level HIV data about multi-
ple outcomes of interest, we created a new statistical model
called Naomi, which triangulates data on population, house-
hold surveys, ART service delivery and HIV testing of preg-
nant women at ANCs. The model produces estimates and
probabilistic uncertainty ranges for HIV prevalence, ART cov-
erage, and the HIV incidence rate stratified by sex, age group
and areas of health administration. Model application was
demonstrated using example datasets from Malawi.
2 METHODS
The model synthesized HIV data from national household sur-
veys and routine service provision data in a Bayesian small-
area estimation framework. Data were stratified by the subna-
tional units at which the health system is administered, often
second administrative level or “district” level. Model inputs
comprised six data sources summarized in Box 1. This sec-
tion provides an overview of the model. Technical details are
described in Appendix S1.
Box 1. Summary of Naomi model inputs and model
outputs. (ANC, antenatal clinic; ART, antiretroviral
therapy; PLHIV, people living with HIV)
Model inputs
Area hierarchy: List of administrative areas used for
health planning (“districts”), geographic boundaries, and
nesting in higher level administrative areas.
Population: Population estimate stratified by district, sex,
and five-year age group (0 to 4, . . . , 80+) over the period
from the most recent household survey to short-term one-
year ahead projection.
Household survey: Data on HIV prevalence, ART cover-
age, and recent HIV infection (if available) from most recent
HIV household survey, tabulated by district, sex and five-
year age group.
Routine ANC testing: data on routine ANC HIV testing
indicators by district and year: (i) number of ANC clients
(first visit), (ii) number known positive at first ANC, (iii) num-
ber already on ART prior to first ANC, (iv) number tested
for HIV, and (v) number tested HIV positive.
ART service delivery data: Number receiving ART at
health facilities in each district at the end of each calendar
quarter stratified by children (0 to 14 years), adult women
(15+ years) and adult men.
Spectrum estimates: The following outputs are exported
from the national or first administrative level Spectrum files
by sex and single-year age: population size, PLHIV, number
on ART, new infections, age-specific fertility rate, HIV preva-
lence among pregnant women, ART coverage among preg-
nant women, number PLHIV unaware of HIV-positive status
(from Shiny90).
Model outputs




∙ ART coverage/number of residents on ART/number of
untreated PLHIV
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Continued
∙ Number and percent aware/unaware of HIV status
∙ Number accessing ART at health facilities in each area
∙ HIV incidence rate/number of annual new infections
∙ Annual ANC clients by HIV status and ART status at first
ANC
Stratifications: All indicators are stratified according to
∙ Geographic areas: All levels of the area hierarchy (e.g.,
national, province, district)
Sexes: both male, female
Age groups:
∙ Five-year age groups (0 to 4, . . . , 80+)
0 to 14, 15 to 24, 25 to 34, 35 to 49, 50 to 64, 65+
15 to 49, 15 to 64, 15+, 50+, all ages, <1, 1 to 4
∙ Time points: Most recent household survey (T1), current
quarter (T2), short-term projection nine months to one
year (T3)
Statistics: Posterior summary statistics are computed
for
∙ Mean, median, mode
∙ Standard deviation, 95% credible interval (quantile-
based)
2.1 Model components
The model involved several steps, summarized in Figure 1,
to produce primary outcomes, HIV prevalence, ART cover-
age and HIV incidence rate by district, sex and five-year age
group at three time points. The three time points represented
the time of the most recent household survey with HIV
serological testing, the “current” period reflecting the most
recently available HIV programme data, and a nine- to 12-
month future projection for short-term programme planning.
First, small-area estimation logistic or log-linear regression
models were specified for cross-sectional estimates of each
outcome (prevalence, ART coverage, incidence) at the time of
the most recent household survey stratified by sex, five-year
age group and district. HIV prevalence and prior ART cov-
erage among ANC clients informed spatial variation in popu-
lation HIV prevalence and ART coverage. The HIV incidence
rate was determined by the HIV transmission rate among
untreated adults, district-level HIV prevalence, and ART cov-
erage. This model reflects basic HIV transmission dynamics
wherein incidence risk depends on the probability of sexual
contact with a partner with unsuppressed HIV infection in the
local population, similar to the EPP model [5].
Second, the HIV population in each district was projected
forward to the current time in a single step based on the
modelled district estimates for new infections and survival
rates from Spectrum estimates [3,4].
The models for HIV prevalence and ART coverage were
linked such that ART service delivery data also informed dis-
trict estimates for the number of PLHIV. To account for per-
sons receiving ART at health facilities outside their district
of residence, the model estimated an odds ratio for seek-
ing treatment in each geographically neighbouring district ver-
sus their district of residence. The predicted number of ANC
clients, HIV prevalence among pregnant women and ART cov-
erage among pregnant women were determined by the mod-
elled sex/age-specific district-level HIV prevalence and ART
coverage and age-specific fertility rates and fertility rate ratios
for HIV-positive women from Spectrum.
Mother-to-child HIV transmissions were not explicitly mod-
elled, but the number of children living with HIV were mod-
elled based on the ratio of child to adult female preva-
lence from Spectrum results and the number of children on
ART. Awareness of HIV status was modelled by applying the
proportion unaware among untreated PLHIV from national
Shiny90 model estimates [22] to the estimated untreated pop-
ulation in each district by sex and age group.
2.2 Model estimation
Statistical likelihood functions were specified for national
household survey, routine ANC testing, and ART service
delivery data. For the most recent household survey, the
survey-weighted counts for the number of HIV-positive
respondents, number on ART, and number recently infected
by district, sex and five-year age group were modelled via a
binomial distribution. The likelihood for recent HIV infection
data also depended on the mean duration of recent infection
and false recent ratio, which are characteristics of the recent
infection testing algorithm applied in a given survey [23].
ANC testing data were summarized as the total number
of ANC clients, the number of clients with HIV status ascer-
tained, the number of HIV positive (either known positive or
tested positive), and the number already on ART prior to first
ANC in the years of the survey and the current year. The
observed number of ANC clients by district was modelled by
a Poisson distribution. The observed number of HIV-positive
pregnant women and number already on ART were modelled
in both years by binomial distributions.
ART service delivery data consisted of the number receiv-
ing ART at health facilities in each district for children, adult
men, and adult women at the time of the survey and most
recent period. The likelihood for these counts was approxi-
mated by a normal distribution, with mean and standard devi-
ation determined by the modelled HIV prevalence, ART cover-
age and cross-district ART attendance probabilities.
2.3 Model outputs
Model outputs consisted of counts and rates for each of the
processes modelled aggregated to multiple geographic, sex
and age stratifications. Box 1 summarizes output indicators.
For all indicators, results were aggregated from the district
level to coarser levels of the area hierarchy (e.g., provincial,
national), stratified by sex and both sexes combined, and by
five-year age group and coarser priority age groups (Box 1).
For the ART attendance model, outputs included the esti-
mated number of ART clients receiving ART between each
neighbouring district pair, the proportion of residents on ART
who attend facilities in each neighbouring district, and the dis-
tribution of districts of residence for those receiving ART in
each district. For each output, the posterior mean, median,
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Figure 1. Overview of model components and processes. ANC, antenatal clinic; ART, antiretroviral treatment; PLHIV, people living with
HIV.
mode, standard error and quantile-based 95% credible inter-
vals (CI) were reported. The posterior mean was the pre-
ferred central estimate.
2.3.1 Calibration to Spectrum estimates
After fitting the model, results may optionally be adjusted
such that the posterior mean of the district-level estimates
aligns to national or subnational Spectrum estimates for the
number of PLHIV, on ART, new infections, and aware of HIV
status. Calibrations may be applied to align by sex and coarse
age groups below 15 years and 15 years and older or by five-
year age groups.
2.4 Implementation and inference
The model was implemented via the R package Template
Model Builder (TMB), which provides analytical gradients for
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the posterior density via automatic differentiation and Laplace
approximation of the marginal posterior [24]. The poste-
rior distribution was approximated with an empirical Bayes
strategy. One thousand samples were drawn from the joint
posterior distribution, conditional on the optimized hyper-
parameters, from which the posterior mean, median, mode,
standard deviation, and quantile-based 95% CI were calcu-
lated for each output indicator.
2.5 Case study
We demonstrated the model using data from Malawi up
to 2018. The three time points used for model estima-
tion were March 2016 for the most recent household
survey, September 2018 for the “current” time period,
reflecting the most recently available ANC and ART service
delivery data for this analysis, and September 2019 as a fur-
ther 12-month short-term projection. The area hierarchy rep-
resented four levels: three regions (North/central/southern),
five health zones, 28 administrative districts and 32 areas
reflecting the 28 districts and four metropolitan areas
(Lilongwe, Mzuzu, Blantyre, and Zomba cities). Population
data were from district population projections from the 2008
household census adjusted to district population estimates
from the 2018 census [25,26]. Malawi Spectrum results
were sourced from the 2019 national HIV estimates file
[27].
Household survey data on HIV prevalence were used from
the Malawi demographic and health survey (MDHS) 2015
to 2016 and Malawi population-based HIV impact assess-
ment survey (MPHIA) 2015 to 2016 [28,29], which were con-
ducted contemporaneously. The MPHIA furnished survey data
on ART coverage and recent HIV infection. Routine data on
the final HIV status of ANC clients and the number cur-
rently on ART at the end of each quarter by the 32 districts
were sourced from quarterly site supervision and monitor-
ing reports published by the Department for HIV and AIDS,
Malawi Ministry of Health [30]. The total number on ART was
distributed to adults (15+ years) and children (0 to 14 years),
assuming 94% were adults based on Spectrum model outputs
for the years 2016 to 2018.
Primary results were not calibrated to Spectrum estimates.
For comparison, we also calibrated results to national Spec-
trum HIV estimates by sex and coarse age group (<15,
15+ years). Finally, we fitted the model without the ART
attendance probabilities, assuming all ART clients attended
facilities in their district of residence.
Demonstration model input datasets are available from
https://github.com/mrc-ide/naomi/tree/master/inst/extdata
[31]. Demonstration datasets did not include the most
current Malawi HIV programme data through 2020,
and household survey inputs were constructed with-
out reference to survey cluster geolocation datasets
(see Supporting Methods for details). For the most cur-
rent and complete subnational estimates produced by
the Malawi HIV programme, refer to UNAIDS AIDSinfo
[32]. R code reproducing the analysis is available from
https://github.com/jeffeaton/naomi-model-paper.
3 RESULTS
Figure 2a illustrates estimates for HIV prevalence in Malawi
among adults aged 15 to 49 years at all levels of the area
hierarchy in September 2018. Estimated national HIV preva-
lence was 8.9% (95% CI, 8.4% to 9.4%). Across districts and
metropolitan areas, prevalence ranged from 3.2% to 17.1%
and was higher in districts in southern Malawi and higher
in metropolitan areas than neighbouring districts (Lilongwe,
Blantyre, and Zomba cities). The relative standard error (RSE)
for district HIV prevalence estimates ranged from 4% to 16%
and was lowest in Blantyre and Lilongwe cities, which were
oversampled strata in the MPHIA survey.
At national level, ART coverage among adults 15 years and
older increased from 67% (66% to 69%) in March 2016 to
77% (73% to 80%) in March 2018. Across districts, ART cov-
erage was more homogenous than prevalence, ranging from
64% to 75% in 2016 and 75% to 82% in 2018 (Figure 2b).
ART coverage was lowest in Blantyre city in both 2016 and
2018, but also increased by the largest amount (11% points).
The estimated HIV incidence rate was higher in southern
Malawi districts, with high HIV prevalence and untreated pop-
ulations (Figure 2c). The RSE for the incidence rate ranged
from 19% to 49%, much larger than for HIV prevalence
or ART coverage. Estimated new infections were lowest in
Likoma, a small island district in Lake Malawi, at 50 (20 to 95)
infections per year and ranged from 230 to 8120 in mainland
districts.
The largest number of PLHIV was in the age group 35 to
39 years for both men and women (Figure 3). Among women,
most new infections were in the age group 20 to 24 years,
most untreated PLHIV were among ages 25 to 29 and the
greatest number on ART were among ages 35 to 39 years.
For men, the greatest number of new infections, untreated
PLHIV and PLHIV on ART were in the age groups 25 to
29, 30 to 34 and 40 to 44, respectively. Relative uncertainty
was much larger for the number of untreated and undiag-
nosed PLHIV by age (median RSE 21%) and for new infections
(median RSE 29%) than for the number of PLHIV or number
on ART (median RSE 10% and 9%, respectively). Similar out-
puts are available for each district or region.
Figure 4 compares district-level estimates for HIV preva-
lence and ART coverage in 2016 with household survey and
routine ANC testing data to which the model was calibrated.
The 80% posterior predictive intervals indicate the range in
which 80% of new observations would be expected to fall.
For HIV prevalence, 68% (43/63) of survey observations fell
within the 80% prediction interval and 87% (55/63) fell within
the 95% prediction interval (Figure 4d). For ART coverage,
81% (25/31) and 97% (30/31) of observations fell within the
80% and 95% predictive ranges, respectively (Figure 4c). Esti-
mates among ANC clients for HIV prevalence (Figure 4b) and
prior ART coverage (Figure 4d) were closely calibrated to the
observed values and correlated to the population prevalence
and ART coverage across districts.
Estimates for ART attendance in neighbouring districts are
demonstrated in Figure 5 for Lilongwe city, Lilongwe dis-
trict excluding the metropolitan area (“Lilongwe rural”), and
Dowa district to the north of Lilongwe in central Malawi. In
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Figure 2. Examples of model estimates. (a) HIV prevalence among adults age 15 to 49 years at all levels of the area hierarchy in Septem-
ber 2018. (b) Antiretroviral treatment (ART) coverage among adults age 15 years and older by district and four metropolitan areas in
March 2016 and September 2018. (c) HIV incidence rate among adults 15 to 49 years (colour) and annual number of new HIV infec-
tions among adults 15 years and older (size of bubble) in September 2018. Estimates reflect posterior mean. Example results did not
include the most current Malawi HIV programme data, and some household survey clusters were randomly allocated to districts; refer
to UNAIDS AIDSinfo for official Malawi HIV estimates [32].
September 2018, 76,300 adults received ART at health
facilities in Lilongwe city, but only 59,100 (54,100 to
64,300) resident PLHIV of Lilongwe city were on ART
(Figure 5a). Conversely, health facilities in Lilongwe rural
provided ART to 24,900 adults, but 40,500 (21,000 to
37,900) resident PLHIV were on ART, and Dowa facili-
ties provided for 12,600 ART clients but 16,800 (13,800
to 20,000) residents were on ART. Thirty-eight percent
(26% to 50%) of Lilongwe rural residents and 39% (27%
to 50%) of Dowa residents received treatment at health
facilities in Lilongwe city (Figure 5b). Among Lilongwe city
residents, 92% (76% to 98%) received treatment in the
city. Among those attending facilities in Lilongwe city, an
estimated 71% (61% to 79%) resided in Lilongwe city, 20%
(14% to 27%) in Lilongwe rural, and 9% (6% to 12%) in Dowa
(Figure 5c).
Calibration to Spectrum estimates very slightly increased
the national estimate for age group 15 to 49 years HIV
prevalence from 8.9% to 9.0% in September 2018; ART
coverage was unchanged from 77% (Figure S1a in Addi-
tional file 1). Relative adjustments were similar across all
districts (Figure S2 in Additional file 1). Calibrated preva-
lence decreased slightly for women and increased for men
and vice versa for ART coverage. Calibrated HIV incidence
was about 40% lower, with a slightly larger reduction for
women than men (Figure S1a in Additional file 1). At baseline
32
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Figure 3. Sex and five-year age group stratified results at national level in September 2018. Similar results are produced by region and
by district. Line ranges reflect 95% credible interval ranges. Population is a fixed model input and does not has uncertainty ranges (top
left). For new infections plot (top right), note that the model does not produce estimates of mother-to-child HIV infections, but the num-
ber of children living with HIV (top centre) are modelled based on relative levels of child to adult prevalence and paediatric antiretro-
viral treatment (ART) numbers. Example results did not include the most current Malawi HIV programme data, and some household
survey clusters were randomly allocated to districts; refer to UNAIDS AIDSinfo for official Malawi HIV estimates [32]. PLHIV, people
living with HIV.
in March 2016, the calibrated estimates had slightly higher
prevalence, 9.4% versus 8.8%, and lower ART coverage at
63% versus 68% uncalibrated (Figure S1b in Additional file
1). Thus, the similar prevalence and ART coverage in 2018
but lower incidence were reconciled by fewer new infec-
tions but a larger increase in ART coverage in the calibrated
estimates.
Applying the model without allowing for ART attendance
in neighbouring districts resulted in implausible estimates for
ART coverage, PLHIV, and HIV incidence (Figure S3 in Addi-
tional file 1). When assuming that all persons on ART reside
in the same district as receiving treatment, estimates for the
HIV prevalence in Lilongwe city increased by 24% from 10.7%
to 13.3% (Figure S3d in Additional file 1), substantially higher
than the MPHIA survey estimate of 10.6% (9.4% to 12.1%).
Estimated ART coverage in Lilongwe city also increased from
75% to 80% and reduced in Lilongwe rural from 75% to 65%,
implying a large difference in ART coverage between Lilongwe
city and Lilongwe rural, which is not consistent with ANC ser-
vice delivery data.
4 D ISCUSS ION
A comprehensive HIV response requires data at the geo-
graphic level at which HIV programmes are implemented [33].
The Naomi model synthesizes multiple subnational HIV data
sources to produce consistent estimates for key indicators
that guide HIV resource allocation, target setting and moni-
toring. We have described key components of the model and
presented illustrative outputs using data from Malawi. The
model has been implemented as an interactive web-based
software tool [34] that provides results in under an hour,
depending on the number of areas, amount of data and data
consistency. The tool has been used in workshops by users
33
















































































































































































































































Figure 4. Comparison of district-level data and model estimates for HIV prevalence and antiretroviral treatment (ART) coverage in
March 2016. (a) HIV prevalence among adults 15 to 49 years; (b) HIV prevalence among antenatal clinic (ANC) clients; (c) ART
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from 38 sub-Saharan African countries as part of the national
HIV estimates process supported by UNAIDS.
A key innovation was to more closely integrate routinely
collected HIV service delivery data into modelled district-level
HIV indicators. There is broader momentum towards relying
on routine data for HIV surveillance and strategic informa-
tion and strengthening health information systems [35]. Rou-
tine ANC data have been used in the EPP model to inform
epidemic trends for several years [36]. We have further used
these data to quantify spatial variation in HIV prevalence and,
for the first time, variation in ART coverage based on the pro-
portion of women on ART prior to the first ANC visit. Com-
bining data about the numbers receiving ART and survey or
ANC data about ART coverage leveraged routine ART service
delivery data to inform estimates of the number of PLHIV in
small areas, analogous to the “service multiplier” method for
population size estimates [37].
Increased reliance on routinely collected service delivery
data is a strength, but also has been a challenge when apply-
ing the model across countries. Model convergence and the
accuracy of results are sensitive to the reliability of service
delivery data inputs, especially about the number receiving
ART. This should be addressed through a three-fold strategy:
(a) continued strengthening of reporting in health information
systems from which data are sourced including routine data
quality reviews; (b) improved data visualization and analyti-
cal tools to review input data, identify inconsistent patterns
and suggest appropriate corrections; and (c) improvements to
our statistical model to be more robust to improbable data
and distinguish true trends from likely reporting errors. The
demonstration data presented here are an example of high-
quality service delivery data curated through the successful
quarterly supervision and quality improvement strategy imple-
mented by the Department for HIV and AIDS of the Malawi
Ministry of Health since 2005 [30,38].
When modelling at small areas, allowing for some persons
to obtain ART in neighbouring districts was important for
reconciling district-level data. While studies confirm this phe-
nomenon in specific settings [39], direct data to quantify this
were limited. Instead, our model relied on probabilistically tri-
angulating data about the number on ART with data on pop-
ulation size, HIV prevalence and ART coverage. This required
crude assumptions applying the same odds of seeking treat-
ment in a district to all neighbouring districts. Estimates for
the number seeking treatment in neighbouring districts may
coverage among adults 15 to 64 years; and (d) ART coverage prior to the first ANC visit. Thick black dash and vertical ranges show
model estimates and 95% credible intervals. Narrow vertical light blue lines indicate 80% posterior predictive intervals, representing
the range in which 80% probability new observations would fall. Posterior predictive ranges account for both uncertainty about true
prevalence and ART coverage and sampling variability based on the sample size for each observation. For HIV prevalence results (pan-
els a and b), districts are sequenced in decreasing order according to estimated HIV prevalence among ages 15 to 49 in March 2016.
For ART coverage (panels c and d), results are sequenced in decreasing order according to estimated ART coverage ages 15 to 64 in
March 2016. Red points indicate data observations from household surveys (a and c) or routine antenatal HIV testing (b and d). In (a)
data points represent district HIV prevalence estimates from two surveys, with each has a different 80% posterior predictive intervals
reflecting the sample size and age distribution for that survey. In ANC data plots (b and d), for comparison the light grey dots indi-
cate posterior mean estimates for prevalence ages 15 to 49 and ART coverage ages 15 to 64 shown in panels (a) and (c), respectively.
*District data for Malawi population HIV impact assessment (MPHIA) 2015 to 2016 survey are based on random allocation of survey
clusters to districts within each of seven survey strata. MDHS, Malawi demographic and health survey.
in some cases be a device for reconciling other data inconsis-
tencies, for example, inaccurate district population input data.
As such, these results should be interpreted cautiously. Spe-
cific data about observed or likely patterns of health system
attendance are a priority to improve estimates and further
realize the potential of routine health system data for HIV
surveillance. Such data could include health system data on
clients’ location of residence, household survey data about
where PLHIV obtain care, geographic and population density
data on distance to health facilities, or other population mobil-
ity data from surveys or inferred from mobile phone or trans-
port data.
While the Naomi model used many of the same data as
Spectrum and draws on Spectrum estimates for some inputs,
the modelling approaches are different. Spectrum and EPP
model the full history of the HIV epidemic, incorporate histori-
cal household survey and sentinel surveillance data, and lever-
age epidemiologic and demographic dynamics. Naomi focuses
on data and estimates for the current time period and short-
term projections and incorporates data that are not currently
used for calibrating Spectrum estimates, including household
survey data and routine ANC data on ART coverage. When
there are discrepancies between Spectrum and Naomi results,
users often choose to calibrate the district-level model results
to align to Spectrum point estimates for the same indica-
tors. These adjustments could result in misaligned estimates
or targets for some locations and should be applied cau-
tiously and with consideration. Where differences are large,
we recommend reviewing the data inputs, assumptions and
results of both models to identify the source of discrepan-
cies. In our case study for Malawi, the raw Naomi results
and Spectrum estimates for HIV prevalence and ART cover-
age were similar for September 2018, but in March 2016 the
Naomi results had lower prevalence and higher ART cover-
age, and Spectrum estimated lower incidence at both times.
The Naomi results incorporated survey data on ART cover-
age, which Spectrum did not, and were therefore more consis-
tent with MPHIA survey estimates for ART coverage in 2016.
Spectrum incorporated a longer data series and more mech-
anistic structure, which results in more stable estimates of
incidence trends. Naomi incidence estimates are sensitive to
inconsistent district-level data due to sparse direct data on
incidence or prevalence trends, and in many applications users
exclude recent infection data to constrain implausible varia-
tion in incidence results.
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Figure 5. Results of antiretroviral treatment (ART) attendance model in September 2018 for three districts in central Malawi: Lilongwe
city, Lilongwe district excluding the metropolitan area (rural), and Dowa district bordering Lilongwe to the north. (a) Estimated number
of adult (age 15 years and older) residents on ART compared to number of adults receiving ART at health facilities in each district. (b)
Percentage who receives ART at health facilities in each district by district of residence. (c) Distribution of district of residence for ART
clients attending facilities in each district. For (b) and (c), bars are presented for all neighbouring districts. Bar heights indicate posterior
mean and vertical ranges indicate 95% credible intervals. Example results did not include the most current Malawi HIV programme data,
and some household survey clusters were randomly allocated to districts; refer to UNAIDS AIDSinfo for official Malawi HIV estimates
[32].
Other geospatial modelling approaches for HIV have uti-
lized spatial data on HIV risk factors and other remotely
sensed data as predictive covariates and used spatially con-
tinuous approaches to modelling HIV prevalence surfaces
[6,10,40]. For parsimony, we did not use predictive covariates
in favour of focusing on modelling more HIV-specific service
delivery data sources. This decision was guided by the findings
of Dwyer-Lindgren and colleagues that inclusion of geospa-
tial covariates only modestly improved the accuracy of spa-
tial HIV prevalence predictions compared to a geostatistical
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model with only household survey and ANC sentinel surveil-
lance [10]. Both predictive covariates and more granular spa-
tial modelling merit further exploration, but must be balanced
with the usability implications of greater data requirements
and computational complexity.
Our model has several additional limitations and opportuni-
ties for further development. First, the model only produced
estimates at two time points and only used data from the
most recent HIV household survey. Many countries have now
conducted three or more surveys with HIV testing, which
other models have incorporated into spatio-temporal mod-
elling [10,41]. Extending the model projection steps to ear-
lier and finer temporal resolution is a natural way to incorpo-
rate earlier surveys and furnish annual and quarterly results,
including HIV incidence trends. Second, the model assumed
the age patterns of HIV prevalence, treatment coverage and
incidence rates were the same across all districts. Data to
inform district-level variation in age patterns are limited. Mod-
elling more granular age-stratified service delivery data is an
opportunity to more flexibly identify age patterns across dis-
tricts, but will make estimates more sensitive to discrepancies
in service delivery data inputs. Third, we assumed HIV sur-
vival was the same in all districts. District-level data on ART
retention and viral load suppression could inform variation in
HIV treatment outcomes and implications for HIV deaths and
PLHIV. We also did not incorporate district-level HIV test-
ing data into estimates of awareness of HIV status. Fourth,
in cases where some data sources were not available, cer-
tain model parameters were not identifiable and consequently
specified as fixed values. Fixing parameters for identifiability
makes model estimates appear relatively more precise rather
than more uncertain. Fifth, we did not account for uncer-
tainty about population size by district, sex and age group,
and did not explicitly model migration between districts and
its impact on district prevalence and ART coverage over time.
Small area population estimates are very uncertain in many
countries where the most recent census was long ago or
the census-enumerated population is different from the “oper-
ational” population accessing health services in the district.
Finally, the statistical calibration method did not account for
uncertainty about model hyper-parameters that determine the
smoothness of model estimates, and we did not fully account
for the clustered survey design. Both are ongoing areas of sta-
tistical research [42].
5 CONCLUS IONS
The Naomi model synthesizes data from household surveys,
population and routine service delivery data at the district
level to furnish estimates of key indicators with probabilistic
uncertainty for HIV programme planning, resource allocation
and target setting for local population areas. There are many
opportunities for improving and further developing small area
estimates and adapting the tools to evolving HIV policy prior-
ities, local HIV programme needs and specific data features in
given settings. Modelling of district-level HIV service delivery
data has enabled national teams to routinely review both data
inputs and model outputs at subnational level, and created a
feedback loop that improves the quality of both. This process
should support continued strengthening of routine health sys-
tem data and encourage further research about patterns of
HIV care seeking to interpret these data.
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